NCT00938431View on ClinicalTrials.gov

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

PHASE2CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Epilepsy

Interventions

DRUG

Lacosamide

Lacosamide oral solution (syrup) 10 mg/mL or 15 mg/mL

Trial Locations (21)

Unknown

025, Sacramento

002, Washington D.C.

012, Tampa

019, Wellington

006, Saint Paul

008, Kansas City

015, New Brunswick

005, Durham

001, Philadelphia

016, Pittsburgh

004, Nashville

026, Austin

022, Houston

020, Norfolk

201, Brussels

200, Edegem

202, Leuven

101, Culiacán

104, Guadalajara

105, Monterrey

103, San Luis Potosí City

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY